Search

You searched for "referral"

1683 results found

The results of the last survey Apr22

5 April 2022 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
The answer to the first question was interesting in that it seems an increasing number of units are doing same-sitting bilateral cataract surgery. It is becoming accepted practice and mainstream. Immediately sequential bilateral cataract surgery (ISBCS) involves performing phacoemulsification with...

NEOS (North Of England Ophthalmological Society) Spring Meeting 2024

23 April 2024
by Matthew Hartley, Trainee, Northern Deanery, UK. In NEOS’ 110th year, the spring meeting was held in Doncaster and centred around ocular oncology and vitreoretinal surgery. The meeting hosts, Umi Harley and Steve Winder from Royal Hallamshire Hospital, arranged a...

NHS leaders must support doctors to act on new GMC guidance to challenge concerning behaviour at work

24 August 2023 | GMC, NHS, Letby, John Holden, MDDUS
Dr John Holden responds to the publication of the revised Good Medical Practice (GMP) guidance from the General Medical Council.

Caring for adults with an ocular tumour

1 December 2015 | | EYE - Vitreo-Retinal
Detection If you screen for an intraocular tumour, dilate the pupil. If the patient is driving, use phenylephrine only. If the patient declines, document this in the casenotes. Don’t forget to look for sentinel vessels, which would indicate a ciliary...

Practice Plus Group: CSR in primary care optometry

28 April 2025
Practice Plus Group Ophthalmology are delighted to offer a virtual accredited event for local referrers: ‘CSR in primary care optometry’Central serous retinopathy (CSR) is the fourth most common medical retinal condition which affects mainly patients of working age. It is...

Practice Plus Group: Mastering vitreoretinal pathology assessment in community optometry

6 May 2025
Practice Plus Group Ophthalmology are delighted to offer a virtual accredited event for local referrers: ‘Mastering vitreoretinal pathology assessment in community optometry’In this course, optometrists will master the art of assessing and distinguishing between common vitreoretinal pathologies right from their...

Practice Plus Group: CSR in primary care optometry (1)

28 April 2025
Practice Plus Group Ophthalmology are delighted to offer a virtual accredited event for local referrers: ‘CSR in primary care optometry' Central serous retinopathy (CSR) is the fourth most common medical retinal condition which affects mainly patients of working age. It...

Practice Plus Group: Identifying candidates for combined glaucoma and cataract surgery: an advanced approach

21 October 2025
Practice Plus Group is delighted to offer an accredited event for local referrers: ‘Identifying candidates for combined glaucoma and cataract surgery: an advanced approach’ During this course, we will delve into the complex interplay between Glaucoma and Cataract, exploring how...

Pituitary tumours: why are they so often missed?

1 August 2017 | | EYE - Neuro-ophthalmology
Part 2: Clinical varieties, anatomical considerations and case report (see also Part 1 and Part 3) For ophthalmologists there are four types of pituitary tumour to be considered, three of which are named according to the hormone secreted, along with...

Preventing blindness from diabetes: planning a programme of service development and research across Malawi

5 April 2022 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
In sub-Saharan Africa 19.4 million people have diabetes; this is projected to rise to 28.6 million by 2030 [1]. Sight loss from diabetes devastates the lives of working people, affecting the financial stability of the families and communities who depend...

In conversation with Clare Abbott (ECLO)

3 October 2022 | | EYE - General
Rosalyn Painter spoke to Clare Abbott, a member of the Eye Clinic Liaison Officer (ECLO) team at Oxford Eye Hospital, about her day-to-day job as an ECLO, how the role can help patients, and the ongoing importance of their work....

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

4 August 2021 | | EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...